BioCentury | Jan 27, 2017
Clinical News

Seciera: Ph III Emerald data

...to week 12 vs. vehicle-treated controls (p<0.0001). Sun gained Seciera through its acquisition of the Ocular Technologies S.a.r.l....
Items per page:
1 - 1 of 1
BioCentury | Jan 27, 2017
Clinical News

Seciera: Ph III Emerald data

...to week 12 vs. vehicle-treated controls (p<0.0001). Sun gained Seciera through its acquisition of the Ocular Technologies S.a.r.l....
Items per page:
1 - 1 of 1